Amphotericin B Zentiva 50 mg, Pulver zur Herstellung einer Infusionsdispersion (i.v.)

7680701770025 CH-70177 Pulver

No image available

Article details

Package size
10
Selling units
10
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
amphotericinum B
50.0 MG Substance Wirkstoff (Principe actif)
phosphatidylcholinum ex soja hydrogenatum
- Substance HNIDK
distearoylphosphatidylglycerolum natricum
- Substance HNIDK
cholesterolum
- Substance HNIDK
int-rac-alpha-tocopherolum
- Substance HNIDK
saccharum
- Substance HNIDK
dinatrii succinas hexahydricus
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
70177
Drug name
Amphotericin B Zentiva, Pulver zur Herstellung einer Infusionsdispersion (i.v.)
Galenic form
PULVID
ATC Code
J02AA01
Authorization status
Z
Dispensing category
A
First authorization
03/03/2026
Authorization expiration date
02/03/2031
IT Number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Package details

Description (FR)
AMPHOTERICIN B Zentiva subst seche 50 mg 10 pce
Description (DE)
AMPHOTERICIN B Zentiva Trockensub 50 mg 10 Stk
Market launch
01/10/2026
Narcotic (BTM)
No

Other package sizes (1)

AMPHOTERICIN B Zentiva subst seche 50 mg 1 pce
1 DUR
GTIN: 7680701770018
View
Buy us a coffee Explore the data